Rene H M Te Morsche

Author PubWeight™ 15.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci U S A 2010 1.79
2 NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J Neurosci 2008 1.70
3 A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease. J Crohns Colitis 2011 1.54
4 Over-expression of COX-2 mRNA in colorectal cancer. BMC Gastroenterol 2014 1.06
5 Alternative splicing may contribute to time-dependent manifestation of inherited erythromelalgia. Brain 2010 1.04
6 High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk. Int J Oncol 2012 0.95
7 COX-2 polymorphisms and the risk for head and neck cancer in white patients. Head Neck 2009 0.95
8 Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver disease. Gastroenterology 2004 0.93
9 Primary erythermalgia as a sodium channelopathy: screening for SCN9A mutations: exclusion of a causal role of SCN10A and SCN11A. Arch Dermatol 2008 0.84
10 EPHX1 polymorphisms do not modify esophageal carcinoma susceptibility in Dutch Caucasians. Oncol Rep 2012 0.83
11 Microsomal epoxide hydrolase genotypes and the risk for head and neck cancer. Head Neck 2008 0.83
12 Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer. Int J Cancer 2010 0.80
13 Autosomal dominant polycystic liver disease in a family without polycystic kidney disease associated with a novel missense protein kinase C substrate 80K-H mutation. World J Gastroenterol 2005 0.78
14 No role for glutathione S-transferase genotypes in Caucasian esophageal squamous cell or adenocarcinoma etiology: an European case-control study. BMC Gastroenterol 2013 0.78
15 The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid. Thromb Haemost 2008 0.77